Follow
Partha Sarathi Biswas
Partha Sarathi Biswas
Associate Professor
Verified email at pitt.edu
Title
Cited by
Cited by
Year
Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis
B Kim, Q Tang, PS Biswas, J Xu, RM Schiffelers, FY Xie, AM Ansari, ...
The American journal of pathology 165 (6), 2177-2185, 2004
3642004
Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice
PS Biswas, S Gupta, E Chang, L Song, RA Stirzaker, JK Liao, G Bhagat, ...
The Journal of clinical investigation 120 (9), 3280-3295, 2010
2702010
IRF-4-binding protein inhibits interleukin-17 and interleukin-21 production by controlling the activity of IRF-4 transcription factor
Q Chen, W Yang, S Gupta, P Biswas, P Smith, G Bhagat, AB Pernis
Immunity 29 (6), 899-911, 2008
2192008
Early events in HSV keratitis—setting the stage for a blinding disease
PS Biswas, BT Rouse
Microbes and infection 7 (4), 799-810, 2005
2152005
Oral epithelial cells orchestrate innate type 17 responses to Candida albicans through the virulence factor candidalysin
AH Verma, JP Richardson, C Zhou, BM Coleman, DL Moyes, J Ho, ...
Science immunology 2 (17), eaam8834, 2017
1782017
MCPIP1 endoribonuclease activity negatively regulates interleukin-17-mediated signaling and inflammation
AV Garg, N Amatya, K Chen, JA Cruz, P Grover, N Whibley, HR Conti, ...
Immunity 43 (3), 475-487, 2015
1502015
Role of neutrophils in IL-17–dependent immunity to mucosal candidiasis
AR Huppler, HR Conti, N Hernández-Santos, T Darville, PS Biswas, ...
The Journal of Immunology 192 (4), 1745-1752, 2014
1252014
Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection
PS Biswas, K Banerjee, PR Kinchington, BT Rouse
Experimental eye research 82 (1), 46-54, 2006
1152006
Herpes keratitis in the absence of anterograde transport of virus from sensory ganglia to the cornea
K Polcicova, PS Biswas, K Banerjee, TW Wisner, BT Rouse, DC Johnson
Proceedings of the National Academy of Sciences 102 (32), 11462-11467, 2005
1012005
CXCR2−/− mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization
K Banerjee, PS Biswas, B Kim, S Lee, BT Rouse
The Journal of Immunology 172 (2), 1237-1245, 2004
992004
IRF4 and its regulators: evolving insights into the pathogenesis of inflammatory arthritis?
PS Biswas, G Bhagat, AB Pernis
Immunological reviews 233 (1), 79-96, 2010
892010
IL-17 metabolically reprograms activated fibroblastic reticular cells for proliferation and survival
S Majumder, N Amatya, S Revu, CV Jawale, D Wu, N Rittenhouse, ...
Nature immunology 20 (5), 534-545, 2019
802019
Dual regulation of IRF4 function in T and B cells is required for the coordination of T–B cell interactions and the prevention of autoimmunity
PS Biswas, S Gupta, RA Stirzaker, V Kumar, R Jessberger, TT Lu, ...
Journal of Experimental Medicine 209 (3), 581-596, 2012
772012
Mice transgenic for IL-1 receptor antagonist protein are resistant to herpetic stromal keratitis: possible role for IL-1 in herpetic stromal keratitis pathogenesis
PS Biswas, K Banerjee, B Kim, BT Rouse
The Journal of Immunology 172 (6), 3736-3744, 2004
752004
Oral epithelial IL-22/STAT3 signaling licenses IL-17–mediated immunity to oral mucosal candidiasis
FEY Aggor, TJ Break, G Trevejo-Nuñez, N Whibley, BM Coleman, ...
Science immunology 5 (48), eaba0570, 2020
722020
Pathogen-specific CD8 T cell responses are directly inhibited by IL-10
PS Biswas, V Pedicord, A Ploss, E Menet, I Leiner, EG Pamer
The Journal of Immunology 179 (7), 4520-4528, 2007
692007
Elucidating the protective and pathologic T cell species in the virus-induced corneal immunoinflammatory condition herpetic stromal keratitis
K Banerjee, PS Biswas, BT Rouse
Journal of leukocyte biology 77 (1), 24-32, 2005
662005
Herpetic eye disease: immunopathogenesis and therapeutic measures
S Deshpande, K Banerjee, PS Biswas, BT Rouse
Expert reviews in molecular medicine 6 (8), 1-14, 2004
642004
Application of new TOPSIS approach to identify the most significant risk factor and continuous monitoring of death of COVID-19. Electron J Gen Med. 2020; 17 (6): em234
P Majumder, P Biswas, S Majumder
Electronic Journal of General Medicine 17, 6, 2020
632020
Expression of RXFP1 is decreased in idiopathic pulmonary fibrosis. Implications for relaxin-based therapies
J Tan, JR Tedrow, JA Dutta, B Juan-Guardela, M Nouraie, Y Chu, ...
American journal of respiratory and critical care medicine 194 (11), 1392-1402, 2016
592016
The system can't perform the operation now. Try again later.
Articles 1–20